Pharmalink is actively seeking new projects to develop and commercialise in the Nordic region.
We in-license and acquire the IP and know how around products at an early stage – a prospective trial and patent application is a good start of a longstanding relationship. We are also seeking clinical stage and near-to-market niche or hospital care products where we can bring our development and marketing expertise to bear. Pharmalink has historical strength in the areas of oncology and inflammation and a flexible approach drawing on our team’s experience in a number of other therapeutic areas. Our primary focus is on products offering the potential to bring clear patient benefits in niche indications.
We have worked with partners in a number of Sweden’s leading medical research institutions including the Karolinska Institute and Uppsala University. Our collaborative approach offers the opportunity for inventors to retain involvement in the project while our proven product development expertise maximises the global commercial potential of projects. We structure our agreements to ensure that our academic partners share fully in the value created by successful projects.
To discuss project ideas, please contact Marek Poszepczynski, Business Development Director, +46 70 377 2273, , .
Link to corporate leaflet.